Abstract
Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine / naloxone, Opioid-Related Disorders, Date of authorisation: 10/11/2017, Revision: 2, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have